发明名称 Method for treating obesity
摘要 The present invention is directed to methods for treating obesity, reducing excessive body weight, treating an obesity-related condition, treating unwanted localized fat deposits, and treating areas of cellulite. The method comprises the steps of first identifying a subject in need thereof, and administering to the subject an effective amount of rhamnolipids. A pharmaceutical composition comprising rhamnolipids can be applied by any accepted mode of administration including oral, intranasal, subcutaneous, percutaneous, intravenous, or intracutaneous administration.
申请公布号 US8765694(B2) 申请公布日期 2014.07.01
申请号 US201313946931 申请日期 2013.07.19
申请人 Rhamnopharma Inc. 发明人 Leighton Anton
分类号 A01N43/04;A61K31/70;A61K31/715 主分类号 A01N43/04
代理机构 Perkins Coie LLP 代理人 Perkins Coie LLP ;Kung Viola T.
主权项 1. A method for reducing excessive body weight from a mammal subject suffering from excessive weight or overt obesity, comprising the steps of identifying a subject suffering from excessive weight or overt obesity, and administering to the subject an effective amount of rhamnolipids, wherein said rhamnolipids are selected from the group consisting of: α-L-rhamnosyl-β-hydroxydecanoyl-β-hydroxydecanoate, α-L-rhamnosyl-(1,2)-α-L-rhamnosyl-β-hydroxydecanoyl-β-hydroxydecanoate, α-L-rhamnopyranosyl-(1,2)-α-L-rhamnopyranosyl-β-hydroxydecanoyl-β-hydroxydodecanoate; α-L-rhamnopyranosyl-(1,2)-α-L-rhamnopyranosyl-β-hydroxytetradecanoyl-β-hydroxytetradecanoate, or a combination thereof.
地址 Oakland CA US